3D-Printed Microfluidics Potential in Combating Future and Current Pandemics (COVID-19)

Recent Adv Drug Deliv Formul. 2022;16(3):192-216. doi: 10.2174/2667387816666220727101214.

Abstract

Coronavirus disease (COVID-19) emerged in China in December 2019. In March 2020, the WHO declared it a pandemic leading to worldwide lockdowns and travel restrictions. By May, it infected 4,789,205 and killed 318,789 people. This led to severe shortages in the medical sector besides devastating socio-economic effects. Many technologies such as artificial intelligence (AI), virtual reality (VR), microfluidics, 3D printing, and 3D scanning can step into contain the virus and hinder its extensive spread. This article aims to explore the potentials of 3D printing and microfluidic in accelerating the diagnosis and monitoring of the disease and fulfilling the shortages of personal protective equipment (PPE) and medical equipment. It highlights the main applications of 3D printers and microfluidics in providing PPE (masks, respirators, face shields, goggles, and isolation chambers/hoods), supportive care (respiratory equipment) and diagnostic supplies (sampling swabs & lab-on-chip) to ease the COVID-19 pressures. Also, the cost of such technology and regulation considerations are addressed. We conclude that 3D printing provided reusable and low-cost solutions to mitigate the shortages. However, safety, sterility, and compatibility with environmental protection standards need to be guaranteed through standardization and assessment by regulatory bodies. Finally, lessons learned from this pandemic can also help the world prepare for upcoming outbreaks.

Keywords: 3D printing; COVID-19; artificial intelligence (AI); microfluidics; pandemic; personal protective equipment (PPE); virtual reality (VR).

MeSH terms

  • Artificial Intelligence
  • COVID-19* / epidemiology
  • Communicable Disease Control
  • Humans
  • Microfluidics
  • Pandemics* / prevention & control
  • Printing, Three-Dimensional
  • SARS-CoV-2